Related Experiment Video

Updated: Dec 27, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.2K

Dilated cardiomyopathies and non-compaction cardiomyopathy

A Hänselmann1, C Veltmann1, J Bauersachs1

  • 1Dept. of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Herz
|February 29, 2020
PubMed

Insights

Dilated cardiomyopathy (DCM) is a common heart failure cause, characterized by heart dilation and reduced function. Genetic diagnostics are crucial for risk stratification and understanding hereditary mechanisms in DCM patients.

Area of Science:

  • Cardiology
  • Genetics
  • Heart Failure Research

Background:

  • Dilated cardiomyopathy (DCM) is the predominant cardiomyopathy and a leading cause of heart failure.
  • It involves left or biventricular dilation and impaired systolic function.
  • Etiologies are diverse, including myocarditis, toxins, and systemic diseases, with peripartum cardiomyopathy as a distinct subtype.

Purpose of the Study:

  • To highlight the increasing role of genetic diagnostics in identifying DCM causes.
  • To emphasize the importance of genetic variants in risk stratification, particularly for arrhythmias.
  • To underscore the link between genetic factors and patient prognosis in DCM.

Main Methods:

  • Review of current understanding of DCM etiologies.
  • Analysis of the impact of genetic diagnostics on DCM patient management.
  • Integration of genetic findings with clinical risk stratification for arrhythmias and heart failure.

Main Results:

  • Genetic mutations are identified in 30-50% of DCM patients.
  • Advances in genetic diagnostics reveal more triggering variants and hereditary mechanisms.
  • Genetic variants significantly influence the risk of arrhythmias, impacting patient prognosis.

Conclusions:

  • Genetic diagnostics are pivotal in understanding and managing DCM.
  • Identifying genetic variants aids in risk stratification for arrhythmias and heart failure.
  • Personalized treatment strategies incorporating genetic information are essential for improving DCM patient outcomes.

Keywords:
Arrhythmias, cardiacGeneticsHeart failureMyocarditisPeripartum cardiomyopathy

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.1K
An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

6.1K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
365
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
423
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
299
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
380
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
249